Trials / Unknown
UnknownNCT01045408
The Effect of Berry Extract on Helicobacter Pylori Eradication
The Adjuvant Effect of Berry Extract on Triple Therapy for Helicobacter Pylori Eradication
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Helicobacter pylori (HP) is the major risk factors of gastritis, gastric ulcers, duodenal ulcers, mucosa associated lymphoid tissue lymphoma and gastric cancer. Helicobacter pylori are found in 70-90% of the population in developing countries and in 25-50% of developed countries.
Detailed description
One-week of triple therapy composed of a proton pump inhibitor plus two antibiotics is currently regarded as the gold standard for HP eradication. However, the eradication rate continues to be disappointing. Poor patient compliance and bacterial resistance are the main factors contributing to treatment failure. Therefore, it is urgently necessary to develop a non-antibiotic alternative therapy to increase the eradication rates of Helicobacter pylori. Some literatures reported that cranberry may inhibit Helicobacter pylori adhesion to the human gastric mucus and may reduce Helicobacter pylori infection in adults. The aims of his experiment were to explore the impact of berry extract on triple therapy for Helicobacter pylori eradication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Berry extract | Berry extract for weeks |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-12-01
- Completion
- 2010-06-01
- First posted
- 2010-01-11
- Last updated
- 2010-01-14
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01045408. Inclusion in this directory is not an endorsement.